Document is current
Any future updates will be listed below
-
Authors
Vogelbacher, Christoph
Sommer, Jens
Bopp, Miriam H. A.
Falkenberg, Irina
Ritter, Philipp S.
Bermpohl, Felix
Attar, Catherine Hindi
Einenkel, Karolin E.
Gruber, Oliver
Juckel, Georg
Flasbeck, Vera
Hautzinger, Martin
Pfennig, Andrea
Matura, Silke
Reif, Andreas
Grotegerd, Dominik
Dannlowski, Udo
Kircher, Tilo
Bauer, Michael
Jansen, Andreas
-
Funding
Funding for this research was provided by:
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Received: 11 December 2023
Accepted: 6 September 2024
First Online: 26 September 2024
Declarations
:
: Project A1 was approved by all local ethics committees and is registered with as NCT02456545 (registration date: 2015-05-28). Project A2 was approved by all local ethics committees and is registered with as NCT02506322. Project B2 obtained ethics approval via the central ethics committee for pharmaceutical studies (BfArM). It is registered with as NCT02039479. All participants provided written informed consent, in accordance with the Declaration of Helsinki, after comprehensive information about study aims and procedures.
: Not applicable.
: CV, JS, MHAB, IF, PSR, FB, CHA, KEE, OG, GJ, VS, MH, AP, SM, DG, UD, TK, MB, AJ did not state any conflict of interest. AR has received honoraria for lectures and/or advisory boards from Janssen, Boehringer Ingelheim, COMPASS, SAGE/Biogen, LivaNova, Medice, Shire/Takeda and cyclerion. Also, he has received research grants from Medice and Janssen.
